Literature DB >> 6126747

Ranitidine in insulin-dependent diabetes.

A J Clark, R W Bilous, H Keen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6126747     DOI： 10.1016/s0140-6736(82)90854-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  The paradoxical effect of cimetidine and ranitidine on glibenclamide pharmacokinetics and pharmacodynamics.

Authors:  R T Kubacka; E J Antal; R P Juhl
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

Review 2.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

3.  The role of ranitidine infusion on glucose, insulin and C-peptide serum levels induced by oral glucose tolerance test in healthy subjects.

Authors:  S Gentile; R Marmo; A Costume; C Orlando; R D'Alessandro; G De Bellis; M Porcellini; M Coltorti
Journal:  Acta Diabetol Lat       Date:  1986 Apr-Jun

4.  Potentiation of the hypoglycaemic response to glipizide in diabetic patients by histamine H2-receptor antagonists.

Authors:  J Feely; W C Collins; M Cullen; A H el Debani; R S MacWalter; N R Peden; I H Stevenson
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.